• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?大剂量类固醇治疗重症新型冠状病毒肺炎：一种新的治疗手段？
Intern Emerg Med. 2021 Aug;16(5):1329-1330. doi: 10.1007/s11739-021-02722-y. Epub 2021 Apr 19.
2
High-dose steroids for the treatment of severe COVID-19 pneumonia: the need of the hour?
Adv Respir Med. 2021;89(5):550-551. doi: 10.5603/ARM.a2021.0084. Epub 2021 Oct 6.
3
High-dose steroids for the treatment of severe COVID-19: comment.大剂量类固醇用于治疗重症新型冠状病毒肺炎：评论
Intern Emerg Med. 2021 Aug;16(5):1415-1416. doi: 10.1007/s11739-021-02766-0. Epub 2021 May 26.
4
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia.新型冠状病毒肺炎后出现的对类固醇有反应的桥脑周围血管增强性慢性淋巴细胞性炎症（CLIPPERS）
Neurol Sci. 2021 Oct;42(10):4373-4375. doi: 10.1007/s10072-021-05472-z. Epub 2021 Jul 17.
5
Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.COVID-19 感染期间使用类固醇与高血糖——医生应该知道的。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102167. doi: 10.1016/j.dsx.2021.06.004. Epub 2021 Jun 10.
6
Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids.芦可替尼治疗类固醇治疗无应答的严重 COVID-19 相关高炎症反应。
Acta Haematol. 2021;144(6):620-626. doi: 10.1159/000516464. Epub 2021 Jun 10.
7
Psychosis associated with suspected SARS-CoV-2 encephalitis with response to steroids: a case report.疑诊 SARS-CoV-2 脑炎相关性精神病，类固醇治疗有效：病例报告。
Infect Dis (Lond). 2022 Feb;54(2):152-156. doi: 10.1080/23744235.2021.1977381. Epub 2021 Sep 22.
8
Steroid-Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination.严重急性呼吸综合征冠状病毒2 mRNA疫苗接种后肝脏的类固醇抵抗性急性细胞排斥反应
Liver Transpl. 2021 Sep;27(9):1339-1342. doi: 10.1002/lt.26097. Epub 2021 Jun 29.
9
Extracorporeal membrane oxygenation for COVID-19 during first and second waves.新冠疫情第一波和第二波期间用于治疗新冠病毒病的体外膜肺氧合
Lancet Respir Med. 2021 Aug;9(8):e80-e81. doi: 10.1016/S2213-2600(21)00262-9. Epub 2021 Jun 16.
10
Vigilance in selection of low-dose versus high-dose steroids in COVID-19.在新冠病毒肺炎中选择低剂量与高剂量类固醇时的注意事项。
Int J Infect Dis. 2021 Aug;109:54-55. doi: 10.1016/j.ijid.2021.06.020. Epub 2021 Jun 15.

引用本文的文献

1
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19.等待新冠病毒病的治愈方法：针对不同严重程度新冠病毒病患者的治疗方法
Infez Med. 2022 Mar 1;30(1):11-21. doi: 10.53854/liim-3001-2. eCollection 2022.
2
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review.新冠后综合征与肺纤维化之间的常见分子途径：一项范围综述
Front Pharmacol. 2022 Mar 4;13:748931. doi: 10.3389/fphar.2022.748931. eCollection 2022.
3
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.细胞因子谱在检测 COVID-19 住院患者严重肺部受累中的作用：IL-8/IL-32 轴。
Cytokine. 2022 Mar;151:155804. doi: 10.1016/j.cyto.2022.155804. Epub 2022 Jan 18.
4
NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.新型冠状病毒肺炎住院患者的自然杀伤细胞和T细胞免疫特征
Cells. 2021 Nov 15;10(11):3182. doi: 10.3390/cells10113182.

本文引用的文献

1
High-dose steroids for the treatment of severe COVID-19.大剂量类固醇用于治疗重症新型冠状病毒肺炎。
Intern Emerg Med. 2021 Aug;16(5):1395-1399. doi: 10.1007/s11739-021-02707-x. Epub 2021 Apr 15.
2
A Follow-Up Study of Lung Function and Chest Computed Tomography at 6 Months after Discharge in Patients with Coronavirus Disease 2019.新冠肺炎患者出院后 6 个月时的肺功能和胸部计算机断层扫描随访研究。
Can Respir J. 2021 Feb 13;2021:6692409. doi: 10.1155/2021/6692409. eCollection 2021.
3
Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study.早期洛匹那韦/利托那韦不能降低COVID-19患者的死亡率：一项大型多中心研究的结果。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.02.011. Epub 2021 Feb 11.
4
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.新冠肺炎出院患者 6 个月的后果：一项队列研究。
Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8.
5
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
6
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
7
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?

作者信息

Cameli Paolo, Bergantini Laura, d'Alessandro Miriana, Bargagli Elena

机构信息

Department of Medical Sciences, Surgery and Neurosciences, Respiratory Diseases Unit, Siena University, 53100, Siena, Italy.

出版信息

Intern Emerg Med. 2021 Aug;16(5):1329-1330. doi: 10.1007/s11739-021-02722-y. Epub 2021 Apr 19.

DOI:10.1007/s11739-021-02722-y
PMID:33876321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8055052/
Abstract
摘要